Table 6 Comparisons of outcomes between matched groups of no corticosteroid and high-dose corticosteroid
From: Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia
Characteristic | No corticosteroid | High-dose corticosteroids | Â | ||
|---|---|---|---|---|---|
n = 122 | n = 122 | p value | |||
30-day mortality | 4 | (3.3) | 6 | (5.0) | 0.7486 |
In-hospital hyperglycemia requiring insulin treatment | 6 | (5.0) | 26 | (21.7) | 0.0002 |
Length of stay, days | 15.4 | ±17.8 | 22.8 | ±18.2 | < 0.0001 |
Length of anitmicrobial treatment, days | 6.9 | ±5.2 | 9.4 | ±6.4 | 0.0005 |
Total cost of all drugs in hospitalization | |||||
 Japanese Yen ± SD | 94,905 | ±222,024 | 145,767 | ±203,214 | < 0.0001 |
 Euro ± SD | 815 | ±1907 | 1252 | ±1745 |  |
 US Dollar ± SD | 937 | ±2193 | 1440 | ±2007 |  |